**SUSTAINABLE TECHNOLOGY ADOPTION SCORE: 73/100**

Technology Adoption: 18/25  
Innovation Leadership: 16/25  
Measurable Impact: 18/25  
Future Strategy: 14/15  
Industry Position: 7/10

Summary assessment
AbbVie demonstrates a mature and well-executed program of sustainable-technology adoption across energy, water, waste and process optimization with validated near‑term targets and measurable reductions (notably >32% Scope 1+2 reduction vs 2021). Its strengths are strong renewable electricity procurement, focused energy-efficiency projects, pilot and commercial wastewater-treatment and process‑intensification deployments, and supply‑chain engagement. AbbVie is not the absolute sector leader on some fronts (net‑zero timing and on‑site renewables scale lag certain peers) but is a solid upper‑mid performer with a credible roadmap and SBTi‑validated targets. Key sources and recent (2022–2025) examples are cited below.

Detailed findings by research area (with recent examples and sources)

Key Technologies Adopted (25 points) — score: 18/25
- Renewable electricity procurement and on‑site PV: AbbVie increased active sourcing of renewable electricity to >60% in 2024 and has installed site solar (Liège PV system supplying ~1/3 of that site, ~120 tCO2e saved annually) and direct PPAs in multiple countries.[abbvie (3-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWCc6VwSYBJlZPz1fvpF-CtmMqwM_g1k4cj1NvT55PF5d83h5FZj8j8azhJb0-wZLWm22-HVqOF8IrEzSF4jUDOR-1WYv0Ahus7mC_e8MxO1BG7xXmnllSI8z-_y-cgbUq0Lp5fju_w09by5aGVEHxGFtfNQRNqNlvR6royjaebbcLrxkJT7MnXnx6aZ4=) [abbvie (3-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFKpxle1uUub-EPeErwuUDw6DbBDYaysNP1vIL3QIiv5wc_z6Co05dcZCiT0GZcnsjvvEjr1j-jSp9JK_sliXTcBbDTGbp9z5IGjghmr-qG4l9anYEpkGhqbcZTQfV2NtNVA0LNYj-zJTkVqKc5dVpBhk3ilY6pv8gssGpzqcswYYdYRJZY4P2QN6qYpzmjiprIN4Ywy5mftN3raP5X4Qc47gZjaf8=) [mja (3-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzjqSlbqmTU4LH1LktEw_o61SejUsSCg5iGWwc9rcCYQ5dam1dBCRacJxOmkVJpj_hsjGUrlGupVoDov2ipUeqelLZXr2cFzp7EdqfEJ7QvV7_SJUhygUe9YjTtL6qOdI0QMaIwdb5HgzUmaAdfKnVR9ymYb29OASC2PeUB6hCvbEfOPSJwEhJy84ASnzQixY)
- Energy efficiency programs and standards: centralized CapEx for energy/GHG projects; ISO certifications (ISO 14001, ISO 50001 at ~43% of sites in 2024) and facility energy programs (e.g., Sligo energy management delivering ~€799k savings and ~2,575 tCO2e/yr).[abbvie (4-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQERyTyejhs1wY1RtcS18XryAyGsKafPHCmYzu8BoRdE9s_jha8jKXcnkMp-TzqBUBA6dY2obVXdTkDxqr8U_XrbMhCwr-zdaMVIS8aLeWHTD8g1Tc4aK6ug5TsG-3WoXNypDy19FJY5ICxWXjFt4Hdt4srHRqg5XMt0kBZjZWdzJ4_-KzGyUqbNmqj2zjf-V6jot-kan2SWcdNRTzUDJTRv56paITXv) [abbviecontractmfg (4-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFrMUi9xaqE4XBGmxwTx_FTA0XkeFbSekPWK0b4q2yvnfZSVGBowNT9HSZ0YIeqBxmJUHF0OYAANbNk2SB61ThMjQ_xIQ5Q6G_rIuCsiXd6RnMMi9JNTQJdQQAqlnSFSCU9C4dRLA_MEJopCTnXRgFMFMlAbkXB7b-ckvYEzCAi3ib5_lYZGpb4_jPW_ZQUxGNC) [cleanenergyministerial (3-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFTrF0ka4VLGWqV3cH7R0I9W8c9iKAPGObHbI7CLIM75Ru4kAj2XuQVgK_a7uAF_Mh1aQeMEn3HtwLpt23JAmP0S8SYG0GRcXfDx4YbpDHdh_jyVSPtTfs20JiLqYCazv507tO8zwKJleM6d3eZkfDI1JL2OWwU9q61um1RWiAT2cXdXJPBjVRjQ_zaQP3_Nh9n)
- Fleet electrification and EV charging: expanded electric/hybrid fleet (3,000–3,500+ vehicles globally) and EV charging infrastructure.[abbvie (4-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQERyTyejhs1wY1RtcS18XryAyGsKafPHCmYzu8BoRdE9s_jha8jKXcnkMp-TzqBUBA6dY2obVXdTkDxqr8U_XrbMhCwr-zdaMVIS8aLeWHTD8g1Tc4aK6ug5TsG-3WoXNypDy19FJY5ICxWXjFt4Hdt4srHRqg5XMt0kBZjZWdzJ4_-KzGyUqbNmqj2zjf-V6jot-kan2SWcdNRTzUDJTRv56paITXv) [abbvie (5-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFDke4mVPTgkKa9C9uZEA5yIlWevuCD0G9H2jFYn3smqAdjsKuwW_1hjsLV2y1chqq3O9fZjaJByYQLAKAtVy9eM970qDiIAsmBlqeJwH_IBWn2TQTD-WiXzarIw_QichhLVjrwrJNYJOXLzImwZn9VsmVMT8Y-N_BDjwteLWFlmGM54kz58s4BUm1MuEbpkG6H5ZgJR4IUtaVvVEgEfvvSZeKEq9Q=)
- Water & closed‑loop systems: closed‑loop water systems at some sites; absolute water withdrawal reduced ~16.9–20% (2015–2024).[abbviecontractmfg (1-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGFPW57hW4SVCqsjtWgVPFgNPdZ22jcUo7QFzT83GX787SWeNoR0IY9tAqJ1pi8oGnsTzIC1xId_EEjYK7PqoIa0SmuaVIBFZDZmTHSHJbYEMBsA5J_hfHiHx_F4XYA8FHxUz4ZVpgesNSLh9AYtEAg4sPtGy2k07ZkH8n5670537XFYp25HHA-mKLndMa4_7Jq) [abbviecontractmfg (3-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEydFjM4tAXyzuc5PUCmzamug1Tr0Pa6XZOsmm6L4-Xs3JUMvI96_8wnZlDbJx2a1cdn5VkfxsbGTMS_ETq4-9otppGLpq1ENpfRie-BfxCROIDvq2vOWnO4CiiboJi-ebkYZG2xMVdo5Qly1y-c6bwMGaiERQqt5R-1XCU7QRfqN8_DyKtQg0pqM-LUyOIKs8=)
- Waste / wastewater tech: pilot and commercial wastewater treatment (Singapore site) reduced hazardous aqueous waste by >70%; Sligo on‑site treatment reduced hazardous waste >60% over two years; exceeded 2015–2025 waste reduction goal (21.7% reduction in 2024).[abbviecontractmfg (3-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEydFjM4tAXyzuc5PUCmzamug1Tr0Pa6XZOsmm6L4-Xs3JUMvI96_8wnZlDbJx2a1cdn5VkfxsbGTMS_ETq4-9otppGLpq1ENpfRie-BfxCROIDvq2vOWnO4CiiboJi-ebkYZG2xMVdo5Qly1y-c6bwMGaiERQqt5R-1XCU7QRfqN8_DyKtQg0pqM-LUyOIKs8=) [abbvie (3-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHzso8TsP_HBykPJkq7MAxz6JRFAZNhdv2PDWJfyMx3FHWbxpT5e0blvg7iqm6NSXI6xulf7BCad1JUnTfmo3LAQF4c1eDrdYIzwhxkfADuDFyTV_IMHKh_R5Skuf46p1DAfTm3fhD3ztmI2ZMnlzVu7QOrT8D265D_EQXB9DBYGc5b4qDqJMXttus=)
- Green chemistry & process intensification: internal green‑chemistry efforts (chemistry-in-water, mechanochemistry), process intensification and digital energy/process optimization pilots to reduce solvent use, waste and energy.[abbvie (4-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFCa7NAz6Q8ZRpyLBN2SmVNCiIQyAdXrnqnKS1FaWgoGUHEpqedXUWEA-xBKqZlBXR6kbxQTgl5arF6rwyVmcMzM4uNM91KN9BiUGtF0AvthxD0ibJmhYRkwrSBKmxSiC4CJ2FpfeHmjTRlcB15SB3XweK26m8MSTWlqOVctgMLmWUsG1PpTdfnt6IvJY030PYpEtpiJ__m7YP1va8qVXQtXSorRU4oO0s0PKop) [abbvie (4-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFxsqgr3c-ttPobewvEsyp3rQYI6eVcdS1i5OEfLMrgfixZhjL2Pw3hVVv6TYJQnpSP1No9wJverDb2FqlEKFAIWY_AXkmOaWO9pzEBxaaB2SvVDGyjOfyjuV446UMn5_zkq53Kl3vcqDLqDhHQ2ammK8LGd47DGDCWrjYrwsntzU9lkUA1R1m0yWdy6MLKbegxttsQHvU49_8kLkZ7gcM=) [youtube (4-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEiSDQdkq8wgVh_e5yfrSFRUkUzmqJjpjvdEyXUPnGBF139Ksjylxjc1W_bVR69VoljB2aDy2KUeUKtrwqE_HNb1tzIL4A4lT0FMTvsKaODbwOPFSH5j1E35WPx94Axk4CRgzwIE2g=)

Why 18/25: AbbVie deploys a broad set of modern sustainable technologies across operations (renewables, efficiency, advanced wastewater treatment, green chemistry pilots). It has several initiatives at site scale, but large‑scale breakthrough techs (e.g., industrial-scale CCUS, grid‑scale battery storage, or company‑wide advanced carbon removal deployment) are not evident in the public record for 2022–2025.

Innovation Leadership (25 points) — score: 16/25
- R&D & programs: AbbVie runs the Spark Innovation Accelerator for employee ideas, invests in green chemistry (chemistry-in-water, mechanochemistry), process intensification, and digital optimization.[abbvie (4-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFCa7NAz6Q8ZRpyLBN2SmVNCiIQyAdXrnqnKS1FaWgoGUHEpqedXUWEA-xBKqZlBXR6kbxQTgl5arF6rwyVmcMzM4uNM91KN9BiUGtF0AvthxD0ibJmhYRkwrSBKmxSiC4CJ2FpfeHmjTRlcB15SB3XweK26m8MSTWlqOVctgMLmWUsG1PpTdfnt6IvJY030PYpEtpiJ__m7YP1va8qVXQtXSorRU4oO0s0PKop) [thesustainableinnovation (4-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHtI8zQFv__GVj7jeAl0_OxGnyLq3EOnaaiM7WDGe4X5-X7p8OJ1HTa6wKLm3ccXDb7sizjM2vhRHyMQgmeCfFJZlDbU_6kylaDmBB9tzy2Bui_hR5zv0HdMLDB3rFcpcWw2ySbcFlrJGYZmUURGqA5x3NyKpTJ)
- Patents and IP: AbbVie is an active patent filer (47k patents globally, >57% active) and was among top filers of environmental‑sustainability patents in pharma in Q3 2024 — indicating some proprietary sustainability innovation.[greyb (4-20)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGH7QhMIZMQ3xY84ZCjphIQ377pWNW3jCgRo5-YZfTKPKGGqsZR6ZP85aAGaANEe-x98gZJZLsqB_Kl_dbk9CZKVigG2Z1cYJS_2A4byJ-_ChkdUyeRHimo2elOCYr0xgeY4QeUrw==) [pharmaceutical-technology (4-21)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEISJKCeECJH5bc-T6dgzggStv8PJJhhM_0rmr5lnN_q_9LZZzNLzpePdav4h12eNttmkm-kvFLGNa9OYUFaKTNcefV8lLxAhJV6stI-h0KgrvJ_JJiLi2PP1f7WEqAgDd6w0ZBUU-wM2ZJmCnbxN9Dg7sBjtO_Q_lzlc2xfZ5XXopocOFHhPM2jZHtPCMhmQ3fB_5ZbJ7jfo5hyUZIi4fwD6fXTNLj2ioJ6ZQ0W_PAg4c3h2HYoX4=)
- Partnerships: many R&D partnerships (mostly drug discovery oriented), and educational/technology collaborations; fewer high‑profile sustainability technology partnerships (compared with partnerships for clinical R&D).[atu (4-12)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHvEkW-0XFwY5idjvVaKp0-8oj53Cvvqv7t6BxTqnqQpWw2do2P2sGSgjueHhhq1P7yfz68ptN3Ve5q0i9rkX0rjjNc9oUjVd1bUEdPae8F0OCQ7N0JQb8Ech0HJsC0rqLATyVqUrVdWaXbLCF3EjFIhzDTHdMFWaCfI9G_cpGmgIzdRKGandrzTo9rUmm1HUbq0juxYpvOUy1jsEkQHBQOyU6O5RqsNp4zylbXDJnE0zQPd8NTGadk0zmFeYxpiDRmAu6ev6ZH) [prnewswire (4-13)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF8JrG6rtSIub7kzu-Np7KEqWNxJ1V_9PXd6mdPK9qdmEgV8oRwmRJglaUeTIBkaxf6RMW3clYfZUhjc4RlLoVx3CObjLPkoooTc6SGjR5D-eV7Tje7GIvEK_ZrL_A09Vds3XhRs2YgXqNLsg0PabIK23oMszlOMXYVgC9In7aE01YkimpeeJatu1M2HYVFTUKfo-lwmMviuynafvcPRYwY4SfdxadnTvTN8AXiKIwi_kImwuGsBFULF3bw81YfViRhPoLimkUKSVlf36o3COtVecau6DLm8lSxkIEU1MIVUEx6ODM=)
- R&D scale: AbbVie’s overall R&D spend (drug R&D) is very large ($10.8B adjusted R&D in 2024), but dedicated capital for environmental tech (pollution control CapEx ~$22M in 2024) is more modest.[abbvie (4-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHvJUNbHmKWY1JUUwAMYShEjMZbiVPMhBq7JGONig-V0GobXYP-5uZO9s9srQCikK6rieyHV-Zkp3Z1b2kCXzWFwBSusGgrYrt8gy2fUKrJStkzaLHHf0PhSqrRDw9vJupLQeWv_0MsXiwzeMCFJYtXuHOpqDRTlrqU02RSwZd5tuFdDE5-mt_iq9Vs) [sec (4-19)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEJgmgceQChiVx7b67HA5Zet3J75FWhGdKQscIgk5TD3jImVajbyP3Ex-bsG_zBRUcPBs0ISImOy8R19-YP39irmGTI8zaV1IuGABWnZj5wwz3NkwrsO0ND2Z_2lsEuKdoCDKrkyegLTeI48WVSEBsVhKlfbxe2r_1GNAwaZSwBdP17T8s7g68dw0p1RI6AVQ==)

Why 16/25: AbbVie shows credible internal innovation programs, pilots that can scale (green chemistry, process intensification) and active patenting in sustainability. However, it is not clearly an industry leader in breakthrough proprietary sustainable technologies (e.g., large‑scale carbon removal, pharma‑specific CCUS, or major industrial R&D consortia focused on sustainability) compared with a few peers that have more aggressive on‑site renewables portfolios or earlier net‑zero timelines.

Measurable Impact (25 points) — score: 18/25
- Scope 1 & 2 reductions: AbbVie reports >32% reduction in Scope 1+2 GHG emissions vs 2021 and reported 2024 Scope 1 ≈ 300,072,000 kg CO2e and Scope 2 ≈ 122,287,000 kg CO2e. Active renewable sourcing rose to ~60.4% in 2024.[abbvie (5-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH8plBSOMe8DzPlnzS-77PRdWyIVUnqsh5kq9x_drLcp_GmyT5eWXoY9cKTzBEw5AoWMidDYEsFscfZY3RhlRAsQJS_6xmQe_juaDOqTByOvCXoDIS7MXZVhKbHc4BxkcLXvqZyrjTb3uR75DPcN3U8OI9yQ6QcC_VZ04voVGOxl4CM9D7YOCUcUuQ=) [ditchcarbon (5-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGwfiXfn6fDcF3eUgHAfi-SJxLFMQNqSwNWEcMmSvlnQ9w2VSBmDlNQsDxyv7Szd6vlXilweM31QDgHPViODqosdyfXsIIfvTgFU1hQabJPyRnzQ9vQbwPE7qspd1VK03cZ5Sl5cIw=) [abbvie (5-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFDke4mVPTgkKa9C9uZEA5yIlWevuCD0G9H2jFYn3smqAdjsKuwW_1hjsLV2y1chqq3O9fZjaJByYQLAKAtVy9eM970qDiIAsmBlqeJwH_IBWn2TQTD-WiXzarIw_QichhLVjrwrJNYJOXLzImwZn9VsmVMT8Y-N_BDjwteLWFlmGM54kz58s4BUm1MuEbpkG6H5ZgJR4IUtaVvVEgEfvvSZeKEq9Q=)
- Renewable electricity effect: active sourcing of renewables reduced Scope 2 by ~10% since 2021; projected to deliver larger reductions by 2030 as procurement reaches 100%.[abbviecontractmfg (5-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFPkz1LLaz2KaNvbX0-8lsXvQRdoE32xDBSwugYbRgqNPpY4lpoX50Un4u36QvrlVaSc9n-uD4SiAOkC--47sfe9RrmfiUStWsbIV3G6DdIeeGUNZStEaNF4-OCvTIoY625jxip78SlfNXB9c7vLAEmG6ob_5UelTXJX6NxD8_NgjjzvJm_sXjpSl5wFEwqcNE=) [abbvie (5-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGzNOjpXtqMLpKqn0w8juoyIRUazIsomnkc-z-Q1SrGZtnbQfKw_MhnysrlLy9mBKiP9BhQdQfxiPGl4P1Gz9tV1rxAUlFaoIU3CffaGoe5bUChPwO83J-i6GG9hGd88F49ewWaXZBiyDQO3SCgrQhUv5Qrlb7VgHWe3VoHX6lCiWQzzGLiC0bs8ec5Ow==)
- Water & waste outcomes: absolute water withdrawal down ~16.9–20% (2015–2024) and waste reduced 21.7% (2015–2024), exceeding intermediate targets; wastewater pilots achieved >70% hazardous aqueous waste reduction at one site and >60% reduction at Sligo after on‑site treatment installs.[abbviecontractmfg (1-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGFPW57hW4SVCqsjtWgVPFgNPdZ22jcUo7QFzT83GX787SWeNoR0IY9tAqJ1pi8oGnsTzIC1xId_EEjYK7PqoIa0SmuaVIBFZDZmTHSHJbYEMBsA5J_hfHiHx_F4XYA8FHxUz4ZVpgesNSLh9AYtEAg4sPtGy2k07ZkH8n5670537XFYp25HHA-mKLndMa4_7Jq) [abbviecontractmfg (3-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEydFjM4tAXyzuc5PUCmzamug1Tr0Pa6XZOsmm6L4-Xs3JUMvI96_8wnZlDbJx2a1cdn5VkfxsbGTMS_ETq4-9otppGLpq1ENpfRie-BfxCROIDvq2vOWnO4CiiboJi-ebkYZG2xMVdo5Qly1y-c6bwMGaiERQqt5R-1XCU7QRfqN8_DyKtQg0pqM-LUyOIKs8=) [abbvie (3-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHzso8TsP_HBykPJkq7MAxz6JRFAZNhdv2PDWJfyMx3FHWbxpT5e0blvg7iqm6NSXI6xulf7BCad1JUnTfmo3LAQF4c1eDrdYIzwhxkfADuDFyTV_IMHKh_R5Skuf46p1DAfTm3fhD3ztmI2ZMnlzVu7QOrT8D265D_EQXB9DBYGc5b4qDqJMXttus=)
- Facility recognition: APL Barceloneta plant earned EPA Energy Star in 2024 — a sign of strong energy performance.[newsismybusiness (0-11)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHNqvTU_4HELy5FP6OlptG3SlIggVcx9Xwza5ndedCF74vQ_Pvyde_1C7dcE_WR93rbcplQsrOFcN2R8OTuWPBWn-U0VJfRPocFY7UnbtlTvkrLm46MrowuBMc_klud4KHAUSDwNDaiSkF8kWn2tEKEDcZv5ouhIsboYnik8rbQPv_z5xIduu_1YRlYkvmD_2qkkMOOV4qeP_886g==)

Why 18/25: The company has clear, quantified improvements in key environmental metrics (Scope 1+2 GHG reduction >32%; water and waste improvements meeting/exceeding targets). These are strong, measurable results but are not in the >50% improvement tier required for top score.

Future Strategy (15 points) — score: 14/15
- Near‑term and validated targets: SBTi‑validated target to reduce absolute Scope 1 & 2 GHG emissions 42% by 2030 (2021 base) and aim for 100% renewable electricity by 2030; supplier targets for SBTi adoption (79.1% of suppliers by emissions by 2027).[abbvie (5-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGzNOjpXtqMLpKqn0w8juoyIRUazIsomnkc-z-Q1SrGZtnbQfKw_MhnysrlLy9mBKiP9BhQdQfxiPGl4P1Gz9tV1rxAUlFaoIU3CffaGoe5bUChPwO83J-i6GG9hGd88F49ewWaXZBiyDQO3SCgrQhUv5Qrlb7VgHWe3VoHX6lCiWQzzGLiC0bs8ec5Ow==) [net0tracker (5-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGcreDqlR8peZ2MvcDVAV6GbCXvrko-9B792M9PU1Q9-qqV7vuoUA4enVldrWgn_AkW3trpJhdKVUtAVetw5r55UZRuCyopEg8BPONmB8Wyl9MPqgUWhVEJtbMe-wVmIl2NS1dpt9ok1boPrJPR1TYj) [ditchcarbon (3-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1IteNsUtfiSIvGLFjpwfpR7983mofciQg-Ktnqv3wgNm1KLiEj7e66ChYBd3J84txlvjkkaqFjKD7pKZh_yzk92QMe3bkL4ya0VU20emfDlylb8pvB_kcQMCyqHOc3MPz8vvlQLE=)
- Governance & reporting: Board oversight via Public Policy & Sustainability Committee, regular ESG reporting, double materiality assessment and TCFD/SASB alignment efforts.[abbvie (1-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEyC9U0NtN7EB1nPCj9fJi1iTUs873PXiOLrBP1yqMcN0GWBW9yMt2-TDmYeTeS8j2bLz6RgOX5YMtJWJ60XrrQRnCNnuBvwO1hpRFKe6xl1fPWt-FuS7iBV6Llj-2U7OPEb2liI374nSrHpRfT6Aq-Iv2yTXoLxxekQc7OXyzT6f9FVn4UvZ_sVZfa) [abbvie (2-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmINMJh1KVQmAAdrSpWfQXfRBwY-_qbAEgd889fdiLbvslt2GtMAZwnXvMawudN3a_6i2BTSd6RwzXKDaaXDuUnSqRoSA8HruDl0seR9eC6VV5-v6QZ7LLIAZ_ZPlOsa6sEO-pUM5B4gUeF3cKpymyizTD1fv4R_NdHqu0nHZKsxPYYjZYz4WDvCwj)
- Roadmaps & investments: centralized CapEx for energy/GHG projects, specific 2025/2030/2035 milestones (25% reduction by 2025 vs 2015 baseline; zero waste to landfill by 2035; water‑per‑unit targets by 2025).[abbvie (2-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEVr1zCFZzkLHKtz-PMy8m8dDvF-ICJtCozJEvH_bwyQtWNzkcdFoSAOf63wxdM5yuk1_4OE5apoxXZM5Im93LNlrEfLWRSe3foVylrlufuVRZ3wFVexbzUUqA-rLdw5mlEf0fZqKsYN-cIminK4So4nuQkZR0v2kGym9a1s92fj37AQwehpmj7KeM7uVGwFNgElg5LAen5QRak1siSDbpo8kuZLjhP) [abbviecontractmfg (2-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHrGryh32tsCqPg4quZPY7tIgcoYpn2Jg32gzLG-x2QOkExik04t9Z3snSPHsmiKk2qZB1rJ3PZZwo59gMgg00C8kg6wITEclda-LiMiwSrI6fs5JDTu42jX0baAEr52tnkeHNIcLcCAcKlHM10em_wqqYiwOG3VOM0_wYYAy-Yydb4Cc07UdJnUHbL3KTzmZiK)

Why 14/15: AbbVie has a comprehensive, time‑bound roadmap with SBTi validation and supplier engagement commitments. The only deduction is for some inconsistencies/ambiguities in public language about longer‑term net‑zero year (see below) and that a few strategic investments (e.g., major long‑duration carbon removal or large industrial decarbonization partnerships) are not prominent.

Industry Position (10 points) — score: 7/10
- Strengths vs peers: AbbVie’s renewable electricity (>60% in 2024), SBTi‑validated targets, and documented >32% Scope 1+2 reduction place it above many peers on some metrics.[abbvie (6-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG9WkQr4jLwTGVMs26iXPTBxjygQIGj7zFlxAKx7xRKVPa7AWmNbr9UbPwoi0zMuravNqY3snkb6NvuIAewVTVjOaiaVsSbES0xGlw9Umuhywmr0SVC0Qt1LqZW-uH4TnoJhmL9thu3NP1kyVogJ5XOUmSrbSC3yBUu4Qqta1hAbDUP85QiC4y9Iz8R) [abbvie (5-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH8plBSOMe8DzPlnzS-77PRdWyIVUnqsh5kq9x_drLcp_GmyT5eWXoY9cKTzBEw5AoWMidDYEsFscfZY3RhlRAsQJS_6xmQe_juaDOqTByOvCXoDIS7MXZVhKbHc4BxkcLXvqZyrjTb3uR75DPcN3U8OI9yQ6QcC_VZ04voVGOxl4CM9D7YOCUcUuQ=)
- Peers comparison: other large pharma (Johnson & Johnson, Roche, Novartis, Pfizer) have some advantages — e.g., J&J and Roche reported higher % renewable electricity in 2024 (≈86–87%), and several peers have earlier net‑zero commitments (e.g., Pfizer ~2040, Novartis 2040, J&J 2045, Roche 2045).[jnj (6-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEnQZjHz8dYSjg6kGICvqO0MW_irkkUlzGBzpgawFUAaDpn8TADgdXiXI8dLegWEpDfE4PePGPjvm2GiWnvwhc2t_S-qm_e36couPzyeZrDsnDxfbsc4K87N_tGHXhf_CmYhVrLsz-BwNlcL5Qb-JzTHkVkWtGetMLE3Cmq_O-dBhuPRYPYFIIdiM-ZuXr25FKHtChEcLl1LEKJY5nm1QKUwW46RMo=) [esgtoday (6-18)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF2kPz3ns1h7cfQbxIphDEtc8rJX29MoBDJvY6Jhe93JpeQ8-M09OSQgYEWbvh-XamSqDNl0Mr51ttjCepNo2XQPyIb5WhrLuqcWjvtnMpKDZ2c-mlQr_PNizthf56sjTa1mDJBHVbYxn_d5uDkAhfqbxXFzf7H0SZu2_g4VPg=) [novartis (6-14)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGPD_22s3vzVBvhvE2TyQzJRUlbE-zyuAgf_tJh1lAVtNGUs5rd82SXDCEEJV2oDw77AXi_61Asc6urWN7gzEv7n4MOBUAXKz-pNUQqXPsdY6iLeHHxvE9Xjs33jplY1F3TKkDUjOnJPw0TbaafuTHujzmFlnIG4cPjlBu3) [europeanpharmaceuticalreview (6-34)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHDXXK0dFOLI6I9wDSV4jP34EB9fSSoiP4zWoBiJ1N0c43Gr1I4HABFYcGOOCDAEQnfeRDuXFFezJXz4wCcWj7vgOpC0MyroYayNOkTFSe15tlDC91aUbYlvP35AnfBKt8WF7NzRs-WUtTYhprgCI1Vr4GYiZpMYuuYYuI6r46YxBsJBW6vtX9abk1Nq9eZcDhicmvjeXXAuUOJzOQ=)
- Third‑party signals: SBTi validation is positive; CDP score “B” and other rankings place AbbVie in the solid middle/high group rather than the absolute leaders.[net0tracker (5-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGcreDqlR8peZ2MvcDVAV6GbCXvrko-9B792M9PU1Q9-qqV7vuoUA4enVldrWgn_AkW3trpJhdKVUtAVetw5r55UZRuCyopEg8BPONmB8Wyl9MPqgUWhVEJtbMe-wVmIl2NS1dpt9ok1boPrJPR1TYj) [mja (5-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEwEz3jyvPH43feOvjN4BH5SikpTUaYOoNIpasx2TaA_FqQLDfNv5o1_z3WcuK4_1X5UH7NaKaQXlGIb0w4uNhSKfNvVPbl1onbBnpElDUtSqZABzHcc007KB-KUBDJvHeucLwdXaM43Hbm5sv6PsayQMiLNccqu8fhS07z-a3wuTkTLxs95TuGVdSySnOs1OP)

Why 7/10: AbbVie is among the stronger performers in pharma but does not clearly outpace leading peers on net‑zero timing or on‑site renewables scale. Overall it ranks as upper‑mid in the sector.

Scoring recap and overall score calculation
- Technology Adoption: 18/25  
- Innovation Leadership: 16/25  
- Measurable Impact: 18/25  
- Future Strategy: 14/15  
- Industry Position: 7/10

Total = 18 + 16 + 18 + 14 + 7 = 73 / 100

Key recent examples (2022–2025) cited above
- Renewable electricity >60% (2024) and target 100% by 2030.[abbvie (5-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH8plBSOMe8DzPlnzS-77PRdWyIVUnqsh5kq9x_drLcp_GmyT5eWXoY9cKTzBEw5AoWMidDYEsFscfZY3RhlRAsQJS_6xmQe_juaDOqTByOvCXoDIS7MXZVhKbHc4BxkcLXvqZyrjTb3uR75DPcN3U8OI9yQ6QcC_VZ04voVGOxl4CM9D7YOCUcUuQ=) [abbvie (3-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWCc6VwSYBJlZPz1fvpF-CtmMqwM_g1k4cj1NvT55PF5d83h5FZj8j8azhJb0-wZLWm22-HVqOF8IrEzSF4jUDOR-1WYv0Ahus7mC_e8MxO1BG7xXmnllSI8z-_y-cgbUq0Lp5fju_w09by5aGVEHxGFtfNQRNqNlvR6royjaebbcLrxkJT7MnXnx6aZ4=)
- SBTi validation (March 2023) for near‑term targets and 42% Scope 1+2 reduction by 2030 (2021 baseline).[abbvie (5-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGzNOjpXtqMLpKqn0w8juoyIRUazIsomnkc-z-Q1SrGZtnbQfKw_MhnysrlLy9mBKiP9BhQdQfxiPGl4P1Gz9tV1rxAUlFaoIU3CffaGoe5bUChPwO83J-i6GG9hGd88F49ewWaXZBiyDQO3SCgrQhUv5Qrlb7VgHWe3VoHX6lCiWQzzGLiC0bs8ec5Ow==)
- Scope 1+2 GHG reduction >32% vs 2021 (reported 2024 values included).[abbvie (5-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH8plBSOMe8DzPlnzS-77PRdWyIVUnqsh5kq9x_drLcp_GmyT5eWXoY9cKTzBEw5AoWMidDYEsFscfZY3RhlRAsQJS_6xmQe_juaDOqTByOvCXoDIS7MXZVhKbHc4BxkcLXvqZyrjTb3uR75DPcN3U8OI9yQ6QcC_VZ04voVGOxl4CM9D7YOCUcUuQ=) [ditchcarbon (5-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGwfiXfn6fDcF3eUgHAfi-SJxLFMQNqSwNWEcMmSvlnQ9w2VSBmDlNQsDxyv7Szd6vlXilweM31QDgHPViODqosdyfXsIIfvTgFU1hQabJPyRnzQ9vQbwPE7qspd1VK03cZ5Sl5cIw=)
- Waste/water improvements: 21.7% waste reduction (2015–2024) and nearly 20% water withdrawal reduction (2015–2024); wastewater pilot >70% hazardous aqueous waste reduction (Singapore) and >60% at Sligo.[abbviecontractmfg (3-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEydFjM4tAXyzuc5PUCmzamug1Tr0Pa6XZOsmm6L4-Xs3JUMvI96_8wnZlDbJx2a1cdn5VkfxsbGTMS_ETq4-9otppGLpq1ENpfRie-BfxCROIDvq2vOWnO4CiiboJi-ebkYZG2xMVdo5Qly1y-c6bwMGaiERQqt5R-1XCU7QRfqN8_DyKtQg0pqM-LUyOIKs8=) [abbviecontractmfg (1-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGFPW57hW4SVCqsjtWgVPFgNPdZ22jcUo7QFzT83GX787SWeNoR0IY9tAqJ1pi8oGnsTzIC1xId_EEjYK7PqoIa0SmuaVIBFZDZmTHSHJbYEMBsA5J_hfHiHx_F4XYA8FHxUz4ZVpgesNSLh9AYtEAg4sPtGy2k07ZkH8n5670537XFYp25HHA-mKLndMa4_7Jq)
- On‑site energy recognition: APL Barceloneta Energy Star (2024).[newsismybusiness (0-11)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHNqvTU_4HELy5FP6OlptG3SlIggVcx9Xwza5ndedCF74vQ_Pvyde_1C7dcE_WR93rbcplQsrOFcN2R8OTuWPBWn-U0VJfRPocFY7UnbtlTvkrLm46MrowuBMc_klud4KHAUSDwNDaiSkF8kWn2tEKEDcZv5ouhIsboYnik8rbQPv_z5xIduu_1YRlYkvmD_2qkkMOOV4qeP_886g==)
- Green chemistry/process intensification pilot work and SPARK accelerator.[abbvie (4-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFCa7NAz6Q8ZRpyLBN2SmVNCiIQyAdXrnqnKS1FaWgoGUHEpqedXUWEA-xBKqZlBXR6kbxQTgl5arF6rwyVmcMzM4uNM91KN9BiUGtF0AvthxD0ibJmhYRkwrSBKmxSiC4CJ2FpfeHmjTRlcB15SB3XweK26m8MSTWlqOVctgMLmWUsG1PpTdfnt6IvJY030PYpEtpiJ__m7YP1va8qVXQtXSorRU4oO0s0PKop) [abbvie (4-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFxsqgr3c-ttPobewvEsyp3rQYI6eVcdS1i5OEfLMrgfixZhjL2Pw3hVVv6TYJQnpSP1No9wJverDb2FqlEKFAIWY_AXkmOaWO9pzEBxaaB2SvVDGyjOfyjuV446UMn5_zkq53Kl3vcqDLqDhHQ2ammK8LGd47DGDCWrjYrwsntzU9lkUA1R1m0yWdy6MLKbegxttsQHvU49_8kLkZ7gcM=)

Limitations, unresolved items and risks
- Net‑zero timing: public sources include slightly inconsistent long‑term net‑zero language (some references say 2050, others cite 2040/2045 commitments in different contexts). This ambiguity slightly affects industry‑position scoring and longer‑term leadership assessment.[thesustainableinnovation (4-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHtI8zQFv__GVj7jeAl0_OxGnyLq3EOnaaiM7WDGe4X5-X7p8OJ1HTa6wKLm3ccXDb7sizjM2vhRHyMQgmeCfFJZlDbU_6kylaDmBB9tzy2Bui_hR5zv0HdMLDB3rFcpcWw2ySbcFlrJGYZmUURGqA5x3NyKpTJ) [net0tracker (6-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHosQ4addYSQ4MJU3ZPD5PwsPBeeHFQeQyPHP6gxepLjeq3AHatf7ho0gjykxb7cqMVjAmqAcPyvemqJqoYWkN7aMs5O-QlQq32bC98cz2HZFASLC2Z3CWnDO_9cNT0dQd6g4g28YuQ-_mlnIDjRwB-bw==)
- Scale of breakthrough technologies: AbbVie has pilots and site‑scale technology deployments but fewer examples of enterprise‑scale deployment of frontier decarbonization technologies (e.g., CCUS, direct air capture, large battery grids) in the 2022–2025 public record.
- Scope 3: progress is underway through supplier SBTi engagement, but full Scope 3 decarbonization remains challenging and is a key determinant of ultimate net‑zero performance.[abbvie (5-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGzNOjpXtqMLpKqn0w8juoyIRUazIsomnkc-z-Q1SrGZtnbQfKw_MhnysrlLy9mBKiP9BhQdQfxiPGl4P1Gz9tV1rxAUlFaoIU3CffaGoe5bUChPwO83J-i6GG9hGd88F49ewWaXZBiyDQO3SCgrQhUv5Qrlb7VgHWe3VoHX6lCiWQzzGLiC0bs8ec5Ow==)

Actionable perspectives (if you need next steps)
- If you’re benchmarking or advising: focus on supplier Scope 3 progress and ambition (supplier SBTi adoption) and on AbbVie’s plans for large‑scale on‑site or PPA capacity expansions and any pilot long‑duration carbon removal partnerships — those will materially shift future scores.
- For investment or partnership screening: AbbVie is a credible partner for scaling green chemistry/process intensification pilots, wastewater treatment commercialization, and renewable procurement collaborations.

References (all citations from the compiled summaries)
- [thesustainableinnovation (0-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGkxpp9_j346e3LAYmp3ZezeMcAkTf2ELgmn_1jzUvpmteN6rzGeRhTbOChcR3lyk7ib1Gc4NF6RkRs7qcdCU8pZ6Cbmys3eZ7MFAkmg1dlv2WxWsWmeYxZHrWcfPpWO1TKQZU3x7P9T19MuQd3Gby8xMSVy9H1)  
- [abbvie (0-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE_klRGvzo0iWUNKbNEBuLX0wTxEBOhAsVLjW_I_rF4bL5QjPKu9mSKMD6NER5j0ShqSbKIu8PI7Mc0p_uLhRttreEOxsqM6EYzwgGkNUnSnt_Zj6T4AhLCGSd-e5CgPPWD-06vIFuqS1GN99mosKy8qMNPougJ5uk_VCWZci0SNNrPhnKERXvElA==)  
- [abbvie (0-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHFHT59Ww4w7O5UWEqxUXTrWV2dcqRZs9PuiCuCtG0-XY0581vSsPujutWCxH10eHQdArdesRW9y2k8983I6eO6TOgEcj4ONVH6tnInVFgMhKCeBAqiNz4G0VvEmexpjzlD1Jz-weH26ZDecttMqF7UUcNitph8RWBEKOadnjnbT1hSOxioxEzvRpG2nS1b-Ose5n7DJayfSqnf0ffHYvDdc-ngxdTC)  
- [abbvie (0-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHGGhCabjgxZ-kS6C8hpwxx9XBkdP9DneO3xr5hLkxv3-g_gVRkXL7l87ojQq4IviXg249vEXw3C-hBxS8IwQ7MZOgw35sUc1_LoZVmdacs18Dq-V0mqCjchQTuzLVHQMYPEMLCqTEwgsmKaYXKpbW1agUBUx671TKiWypygP8vmAS-hzcZ1llwPF3W76g=)  
- [net0tracker (0-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEtngywkUqEUDvjdGVUOUxxx1WccRe_vs11bt4xu9efXpYxKQ6Q5orj_umktkS5gG9Aq4Z9BqBYWAJmYTHZPr006zFoo7On_nH5tIi5_JMeF5eaA3FHue-DfI4MawlPgfd-snAOe4XNqvDJnFRaHYF7vw==)  
- [svp (0-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGgZFb2WIMvPCzbNwRuXHg4LkI0HJNLIPyFsCKgsTey2MAn09mfqpjiDgR-t51OghT3AIBlwbOQCY2S6bnHzkYTNie5brfdSvKoWryN8-_DKEMKoCmz3FIMLV5oqGYY1HKmTF7MdpmaqcYv3QDrPtdgf0TbClU9h9oQtSa4jcKNRhCnJaPYnBghPvB-1CHOqCJfbSW6-Cg9E7SY)  
- [abbviecontractmfg (0-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGuXSN2bvXt5FzIfGbek7vM-XB-T99iP2RHoHAQvnVkSaqGTc3OlbejsN_hoQE-gkfycCcrYS0k2z0n8JIUPo6XvUxpOmx8QQFFCCdc9V2YccQ4QCAUraY396AXmXT7dLnsf2z2GEj4q7JSfXw4FKTDUDMjK9PQqveNgW6g7Vys8VoHSbI3eI3_s_NnQ38cBKn3)  
- [ditchcarbon (0-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHg_yzBnZyTo8bvpSgCXe-fCO1eW8WUesyJ0136DDaFfkbPekADrfhpqZo35LRzVh_QdbBHbyw-VaC4Bc7VUwNE94gOW8alaCMFxo0tGm9VwPwHDD7aSmh5sfWR2wujtllEsJOLtXf_)  
- [abbvie (0-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH1s0SJIz6glScQC9aA_OnHmUN3hqU4_ZDDXV2azzyAiaXkdqmtFC9e7i1kaNNegzTbrCL-ern0ZZwfheW415UaYKU9AOyWAE_TBX2E4c392dLkfRv2sP6wYS91caUwOZVkVeePx6Kcd9AG7jT1wHgTXHz0PzXhFoC1aQtiZWUOwA6nyj3lraHXSO6X__6rrek=)  
- [newsismybusiness (0-11)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHNqvTU_4HELy5FP6OlptG3SlIggVcx9Xwza5ndedCF74vQ_Pvyde_1C7dcE_WR93rbcplQsrOFcN2R8OTuWPBWn-U0VJfRPocFY7UnbtlTvkrLm46MrowuBMc_klud4KHAUSDwNDaiSkF8kWn2tEKEDcZv5ouhIsboYnik8rbQPv_z5xIduu_1YRlYkvmD_2qkkMOOV4qeP_886g==)  
- [abbvie (1-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEyC9U0NtN7EB1nPCj9fJi1iTUs873PXiOLrBP1yqMcN0GWBW9yMt2-TDmYeTeS8j2bLz6RgOX5YMtJWJ60XrrQRnCNnuBvwO1hpRFKe6xl1fPWt-FuS7iBV6Llj-2U7OPEb2liI374nSrHpRfT6Aq-Iv2yTXoLxxekQc7OXyzT6f9FVn4UvZ_sVZfa)  
- [abbviecontractmfg (1-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGFPW57hW4SVCqsjtWgVPFgNPdZ22jcUo7QFzT83GX787SWeNoR0IY9tAqJ1pi8oGnsTzIC1xId_EEjYK7PqoIa0SmuaVIBFZDZmTHSHJbYEMBsA5J_hfHiHx_F4XYA8FHxUz4ZVpgesNSLh9AYtEAg4sPtGy2k07ZkH8n5670537XFYp25HHA-mKLndMa4_7Jq)  
- [abbvie (1-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHZIKHiycVHrDCOvnEEYZ7--bpHZrLVvQ95zLPV6M8xLHsOn6ST5t9ulgxl621RiFPuEs9Us4jmLF_m2r0g7JKVdTfPCi3FCiR_IReqi45E-G_UdEk2B6tgNFw_FcHvhZhhZ3Ot9GcDzYrf1N5mBUaoizNSWuHm6PussCSPyswjz4P3BQCCcDfL7LGjTwBE1uzp0MQVDg1xbst545FocIEbWYUe4lie)  
- [thesustainableinnovation (1-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFOH7Lo97C1xlsIb7uY6qfcFxvgzKfLGPbcH1DOIJ7haTJnF7ptrcEXC91EpENEAvRwEpDZWBN8bZUEb1BI25wY6WSVdF9uy7Zhfc_3oOMOmlf_dgfQJkOrEVPlMNgwAq1Zsj6coaRmFWKc8p0RhxmaEdV9FeN_)  
- [net0tracker (1-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGaTJKaU5Ml_hG0PU8WFY_-A0lJ1dkOhJzgzTmZTEFmfaL4bfelnRcgAJGHr0L0VBPS55HCyyIVJUewCjiAdrgFYSUlCL4CMMhhg7PgUPc85o6sPARjCOlHepQd5BV1w1XAsBZp6f8I-jSS02ukZmupWw==)  
- [thesustainableinnovation (2-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE5GHvK8CM-lhZj_julcue0NiNqBbNKC4jJwle-hd3ZE5vAKuwdS_KKdl1Kq9sM5_I4Lp2vcZE0FBs-pYbTfWR5nrKT6PjowlWm6ZrODc-iqX_ReOsHFJslsNjsAeM8d8lEl4EuNDv8eyXQqze4NkjYC9KrrV52)  
- [abbvie (2-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEVr1zCFZzkLHKtz-PMy8m8dDvF-ICJtCozJEvH_bwyQtWNzkcdFoSAOf63wxdM5yuk1_4OE5apoxXZM5Im93LNlrEfLWRSe3foVylrlufuVRZ3wFVexbzUUqA-rLdw5mlEf0fZqKsYN-cIminK4So4nuQkZR0v2kGym9a1s92fj37AQwehpmj7KeM7uVGwFNgElg5LAen5QRak1siSDbpo8kuZLjhP)  
- [ditchcarbon (2-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEeOqO1FETUuCxLqqdvZ0A1SbaqrADShIhlPdzC_wsLmF4D6vpm812YlWLcC3_faGkWZYbkO8RFK3IfiY_xLxNzn_086ag8RmjOj9qXKOr6WJabhpfeO5IfUFQH_7VblFRemV_eSIaJ)  
- [abbviecontractmfg (2-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHrGryh32tsCqPg4quZPY7tIgcoYpn2Jg32gzLG-x2QOkExik04t9Z3snSPHsmiKk2qZB1rJ3PZZwo59gMgg00C8kg6wITEclda-LiMiwSrI6fs5JDTu42jX0baAEr52tnkeHNIcLcCAcKlHM10em_wqqYiwOG3VOM0_wYYAy-Yydb4Cc07UdJnUHbL3KTzmZiK)  
- [abbvie (2-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFKs2IFrPt0xAQjYhVSNz42U6AxiTFX_k9n1IZt1Wen1sWPdsmBMiGuS9hM51S4E6X3qKkhf1WzwPnOpWb8xH1LIGozn3SPPQ3qUsgJI0EY8wZOx3zZxIviQCmRN-On4qeMYGnIk409Ms_5i6HGR7GxcQ4TgDlMQfxNEAfhpz8GVlXYtDWjPEadNOPsgUQ=)  
- [abbvie (2-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmINMJh1KVQmAAdrSpWfQXfRBwY-_qbAEgd889fdiLbvslt2GtMAZwnXvMawudN3a_6i2BTSd6RwzXKDaaXDuUnSqRoSA8HruDl0seR9eC6VV5-v6QZ7LLIAZ_ZPlOsa6sEO-pUM5B4gUeF3cKpymyizTD1fv4R_NdHqu0nHZKsxPYYjZYz4WDvCwj)  
- [responsibilityreports (2-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGQXKALPJg2LZ44QGL3906NwbRK02csqCupQfIIZnp8NB0LibbAZipiFs9432fgTUQ4MLshd0dq1L4psd6OOeHkzsBmfrHUSQ15HxHC3maBEnMMMbAwEeRzrUZyzCju1dMWBmHcfMNEzPfYlaC6xoN6wU0o955_W4G6yXtCQW_PsjiKpo7F3G4mPkznkKHVwuOcDyZ6OAvHQyR1zV8=)  
- [abbvie (2-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEBe6gk1ZHVfdWXlpPCIyKKEGdJO0wsis_7ErSDhm3MmjjdU4DoT8rYRA43bnX9hnoeXnH-YAkzJLM47IiiU1PRuraGwNB5tFNxD3IVB79IafG9R_Gthlclg1e_0BeZ58xrpFyq9SKt7iRXdEAUuLGX_XP36vGwjTERVTSnqrw-FDOQaYAKckAKhQ==)  
- [abbviecontractmfg (3-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEydFjM4tAXyzuc5PUCmzamug1Tr0Pa6XZOsmm6L4-Xs3JUMvI96_8wnZlDbJx2a1cdn5VkfxsbGTMS_ETq4-9otppGLpq1ENpfRie-BfxCROIDvq2vOWnO4CiiboJi-ebkYZG2xMVdo5Qly1y-c6bwMGaiERQqt5R-1XCU7QRfqN8_DyKtQg0pqM-LUyOIKs8=)  
- [abbvie (3-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHzso8TsP_HBykPJkq7MAxz6JRFAZNhdv2PDWJfyMx3FHWbxpT5e0blvg7iqm6NSXI6xulf7BCad1JUnTfmo3LAQF4c1eDrdYIzwhxkfADuDFyTV_IMHKh_R5Skuf46p1DAfTm3fhD3ztmI2ZMnlzVu7QOrT8D265D_EQXB9DBYGc5b4qDqJMXttus=)  
- [abbvie (3-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFWCc6VwSYBJlZPz1fvpF-CtmMqwM_g1k4cj1NvT55PF5d83h5FZj8j8azhJb0-wZLWm22-HVqOF8IrEzSF4jUDOR-1WYv0Ahus7mC_e8MxO1BG7xXmnllSI8z-_y-cgbUq0Lp5fju_w09by5aGVEHxGFtfNQRNqNlvR6royjaebbcLrxkJT7MnXnx6aZ4=)  
- [abbvie (3-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFKpxle1uUub-EPeErwuUDw6DbBDYaysNP1vIL3QIiv5wc_z6Co05dcZCiT0GZcnsjvvEjr1j-jSp9JK_sliXTcBbDTGbp9z5IGjghmr-qG4l9anYEpkGhqbcZTQfV2NtNVA0LNYj-zJTkVqKc5dVpBhk3ilY6pv8gssGpzqcswYYdYRJZY4P2QN6qYpzmjiprIN4Ywy5mftN3raP5X4Qc47gZjaf8=)  
- [abbvie (3-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHSwsfLQx0PN5VLYdsWaRGOBejhOWGIdsnCy9Ov-2UWL85UtdwGXkpzIg7Zxun4z00QlSO0F8lVQMA0V-657ZIEdXpMTM-u4d1oXIKKeLOCca-MgBalPi1DY7WzBvO3wk5ZYqDUNmgRU2YtMk1DWg-Pf6soH6Bht1Cdk5dSZX42hEu7W8k-Way68qTFgF2STq1FFQOjv55YKrp4Bqom0yJkHINoh9c-nG3kBkwTWNs9nXqLJI4_7XE=)  
- [thesustainableinnovation (3-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHwt2Ihv1UQBa4E-rbVf4fPlb0dbSw0K9_T-MViiDqOFov7UP4mz1axGaho1AlamDyJfpZTtFcXUGEoZ-k87FNcP3SwN_XKexLWeFHNtTtWxhPmbnrHxnVr7NSgzFKwd2Z34KTJlabrXn1sYTgB71LoI4wuGNI=)  
- [mja (3-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmzjqSlbqmTU4LH1LktEw_o61SejUsSCg5iGWwc9rcCYQ5dam1dBCRacJxOmkVJpj_hsjGUrlGupVoDov2ipUeqelLZXr2cFzp7EdqfEJ7QvV7_SJUhygUe9YjTtL6qOdI0QMaIwdb5HgzUmaAdfKnVR9ymYb29OASC2PeUB6hCvbEfOPSJwEhJy84ASnzQixY)  
- [cleanenergyministerial (3-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFTrF0ka4VLGWqV3cH7R0I9W8c9iKAPGObHbI7CLIM75Ru4kAj2XuQVgK_a7uAF_Mh1aQeMEn3HtwLpt23JAmP0S8SYG0GRcXfDx4YbpDHdh_jyVSPtTfs20JiLqYCazv507tO8zwKJleM6d3eZkfDI1JL2OWwU9q61um1RWiAT2cXdXJPBjVRjQ_zaQP3_Nh9n)  
- [abbvie (3-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEVbHYL9XV_TuL1lb8bFOUz25VhFVMD1tiyYTWs476KnB2u06NhMjBZgbhz9MeRnEBBg-_SSR11dWeQxyniYrikvwLUefwT4Zk196E842E--uxvZQY-4Syw-aNgBhHH2oigOE5a4nlNSRaIC2bGXR_YOYzefxMczJsZKt81WYpSf4ESz-DXB5oBzG49oXR-6A==)  
- [abbvie (4-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFVhPW-dmdK5oxVXml2OX9vliJC7w8ngVDOIBRNpiVKE6XdTlFFOa7ONV7ZRVJjsWOfOq4aF2RVfu-hhWOEaBcRX3HoHjvp1JfTTTnjvdFziEjCnuUCbqsO6HSjOH2E9vP90g1BvOcF-FScsEiN70_FE0rXqhrYghTLHPsoYzLbTMNyRAtdWnjf8_XW11Y=)  
- [abbvie (4-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQERyTyejhs1wY1RtcS18XryAyGsKafPHCmYzu8BoRdE9s_jha8jKXcnkMp-TzqBUBA6dY2obVXdTkDxqr8U_XrbMhCwr-zdaMVIS8aLeWHTD8g1Tc4aK6ug5TsG-3WoXNypDy19FJY5ICxWXjFt4Hdt4srHRqg5XMt0kBZjZWdzJ4_-KzGyUqbNmqj2zjf-V6jot-kan2SWcdNRTzUDJTRv56paITXv)  
- [abbvie (4-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHvJUNbHmKWY1JUUwAMYShEjMZbiVPMhBq7JGONig-V0GobXYP-5uZO9s9srQCikK6rieyHV-Zkp3Z1b2kCXzWFwBSusGgrYrt8gy2fUKrJStkzaLHHf0PhSqrRDw9vJupLQeWv_0MsXiwzeMCFJYtXuHOpqDRTlrqU02RSwZd5tuFdDE5-mt_iq9Vs)  
- [abbvie (4-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFfbOWMSmAOQxAQyABQd7e25gR9ZVGZ8YQ_BAa_3N2VsUGJBvQvRn-FBgdLTdUvq63pUHeYurlr1HtWfb2iHu9ltOawahKuSqWMcdZFEoshb-KDmtxrlfu1gnwAiy9rQi7ePzB2o-E32P1eYUADudcUHuN43VJJLP1TaaqEqvHn5odBbpFTSXxcanzxo33nYSQ=)  
- [thesustainableinnovation (4-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHtI8zQFv__GVj7jeAl0_OxGnyLq3EOnaaiM7WDGe4X5-X7p8OJ1HTa6wKLm3ccXDb7sizjM2vhRHyMQgmeCfFJZlDbU_6kylaDmBB9tzy2Bui_hR5zv0HdMLDB3rFcpcWw2ySbcFlrJGYZmUURGqA5x3NyKpTJ)  
- [abbviecontractmfg (4-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFrMUi9xaqE4XBGmxwTx_FTA0XkeFbSekPWK0b4q2yvnfZSVGBowNT9HSZ0YIeqBxmJUHF0OYAANbNk2SB61ThMjQ_xIQ5Q6G_rIuCsiXd6RnMMi9JNTQJdQQAqlnSFSCU9C4dRLA_MEJopCTnXRgFMFMlAbkXB7b-ckvYEzCAi3ib5_lYZGpb4_jPW_ZQUxGNC)  
- [abbvie (4-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFCa7NAz6Q8ZRpyLBN2SmVNCiIQyAdXrnqnKS1FaWgoGUHEpqedXUWEA-xBKqZlBXR6kbxQTgl5arF6rwyVmcMzM4uNM91KN9BiUGtF0AvthxD0ibJmhYRkwrSBKmxSiC4CJ2FpfeHmjTRlcB15SB3XweK26m8MSTWlqOVctgMLmWUsG1PpTdfnt6IvJY030PYpEtpiJ__m7YP1va8qVXQtXSorRU4oO0s0PKop)  
- [abbvie (4-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFxsqgr3c-ttPobewvEsyp3rQYI6eVcdS1i5OEfLMrgfixZhjL2Pw3hVVv6TYJQnpSP1No9wJverDb2FqlEKFAIWY_AXkmOaWO9pzEBxaaB2SvVDGyjOfyjuV446UMn5_zkq53Kl3vcqDLqDhHQ2ammK8LGd47DGDCWrjYrwsntzU9lkUA1R1m0yWdy6MLKbegxttsQHvU49_8kLkZ7gcM=)  
- [youtube (4-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEiSDQdkq8wgVh_e5yfrSFRUkUzmqJjpjvdEyXUPnGBF139Ksjylxjc1W_bVR69VoljB2aDy2KUeUKtrwqE_HNb1tzIL4A4lT0FMTvsKaODbwOPFSH5j1E35WPx94Axk4CRgzwIE2g=)  
- [youtube (4-11)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHsgjzugYUoaRs9rQLa7NzfugEIqVrWC1Rqwm6g0oSHp7u6Ru3DGCH2xR326ur6F8wvgI4NfQmVm995h91cH3MfkS66r0XQKkqoZrxcK7Onza56eCyNeIHgyIAvbDyKChLdm3QBf98=)  
- [atu (4-12)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHvEkW-0XFwY5idjvVaKp0-8oj53Cvvqv7t6BxTqnqQpWw2do2P2sGSgjueHhhq1P7yfz68ptN3Ve5q0i9rkX0rjjNc9oUjVd1bUEdPae8F0OCQ7N0JQb8Ech0HJsC0rqLATyVqUrVdWaXbLCF3EjFIhzDTHdMFWaCfI9G_cpGmgIzdRKGandrzTo9rUmm1HUbq0juxYpvOUy1jsEkQHBQOyU6O5RqsNp4zylbXDJnE0zQPd8NTGadk0zmFeYxpiDRmAu6ev6ZH)  
- [prnewswire (4-13)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF8JrG6rtSIub7kzu-Np7KEqWNxJ1V_9PXd6mdPK9qdmEgV8oRwmRJglaUeTIBkaxf6RMW3clYfZUhjc4RlLoVx3CObjLPkoooTc6SGjR5D-eV7Tje7GIvEK_ZrL_A09Vds3XhRs2YgXqNLsg0PabIK23oMszlOMXYVgC9In7aE01YkimpeeJatu1M2HYVFTUKfo-lwmMviuynafvcPRYwY4SfdxadnTvTN8AXiKIwi_kImwuGsBFULF3bw81YfViRhPoLimkUKSVlf36o3COtVecau6DLm8lSxkIEU1MIVUEx6ODM=)  
- [pharmtech (4-14)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGo7ktk9qWYQjb0G8N4hPuXDkOQTTvs6Je7MpUlJW2C9A5QIiwH5XpQpg8r_cf2Et1WLSw1ajojyIOdQ8h7kgOf3HYnPLVfK-pjODT3cLP9Bjyl2xDtxYiPuq-aaSSq4vGfrogszcDHs8huNgSY82v5zsFCohtLulI1wW3IFLEg-gFe_Ky-b8O4-Q1crsiKKRQtjHVhz1Y_)  
- [prnewswire (4-15)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH-x0NXUfMmxIG5YyU3K8-ntZDcgi5OvWohl80j1ZgUjsN-se4FQPhkdpotRYQcJvn3QJSvytdc8tKaGcb700b966yReOfKCAhkvO1Zwv6Ax2g4Kqk3PDE46XQoSccbUOfuWGwBOnHk_BrNmHOcKfsUhgMaT45VNtKHhzzIDQ4OxCUBrgGWxbmGTWXG9u32aWeKWV4ZtSS7cUjxGYf1cmZmhhKP-raY3cjFiLFkBseDKMhOx_dJf72mGNLI6d8i8Oq0u2nk0GQMdPYzEV_Yvz-SuAVc1KvPwFnoWrnyvdMEz_iJ1nBd_USnVPyyVsLe-SqcO-vZVYsImyxYrq2HaRfISqYUxTTx9fM3)  
- [prnewswire (4-16)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEC67T2MERp0LA4qYF2Tp1T9V3i2wmssUhhkbxadCTuAiBzqquodHWpvOVc8F3CL3KX5iul4p-GLeLD2S86IgKWKNkKBfIbiP-yb2UIYnMYuypPwnIJC7HeHUYHLLEgGUJKkG-qF3H4zom3XZS3ErTDM0X8oU6UUSyE7ksbfq0OlBjJ2BVAmQ_g2G0dqRwIIvB4DNS2HeWHYQWddm0-jPlmvwEgQqXCkv1xz2Ae1JG0cNnkqrg7WScVfd3CSxhEMU1FRhwjfb4Lz0FsNJkcbjWyv4IHCxuqy0KmI0LJbtyH89ejgEI6tAf_MQKL4uZrFuOFY7c=)  
- [nasdaq (4-17)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFwbLQXsrTdDwUZ2aZ1sswgF39VYtH918JpblG0LmubbUQgbMuRjGOgoLX3FVRod7jCi_Y3_rYK7IBVSPjLn-TH1BlQVazn3dSdIbDOjoc_8Y__Dula4RHrjxROSPSngS0Gu4CwL6U0oZozQkOkkrrLJjVimvj0zZLMgkLubgWKmIeh-m_kSP04a8Nvw46GI1EwdsPn2KHQ)  
- [abbvie (4-18)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE6D8qQ6ejNAYXnxq3FYE_CwXkOzcScB7y4HEhr8jyGEYHkE-85VSluwM6-nS33pcORsDa2lLx4BW8XXSJ-rLDAkRlV50GjEeEpoJ5fp95trWdip92tBd9OJ0GCD9FQ)  
- [sec (4-19)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEJgmgceQChiVx7b67HA5Zet3J75FWhGdKQscIgk5TD3jImVajbyP3Ex-bsG_zBRUcPBs0ISImOy8R19-YP39irmGTI8zaV1IuGABWnZj5wwz3NkwrsO0ND2Z_2lsEuKdoCDKrkyegLTeI48WVSEBsVhKlfbxe2r_1GNAwaZSwBdP17T8s7g68dw0p1RI6AVQ==)  
- [greyb (4-20)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGH7QhMIZMQ3xY84ZCjphIQ377pWNW3jCgRo5-YZfTKPKGGqsZR6ZP85aAGaANEe-x98gZJZLsqB_Kl_dbk9CZKVigG2Z1cYJS_2A4byJ-_ChkdUyeRHimo2elOCYr0xgeY4QeUrw==)  
- [pharmaceutical-technology (4-21)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEISJKCeECJH5bc-T6dgzggStv8PJJhhM_0rmr5lnN_q_9LZZzNLzpePdav4h12eNttmkm-kvFLGNa9OYUFaKTNcefV8lLxAhJV6stI-h0KgrvJ_JJiLi2PP1f7WEqAgDd6w0ZBUU-wM2ZJmCnbxN9Dg7sBjtO_Q_lzlc2xfZ5XXopocOFHhPM2jZHtPCMhmQ3fB_5ZbJ7jfo5hyUZIi4fwD6fXTNLj2ioJ6ZQ0W_PAg4c3h2HYoX4=)  
- [justia (4-22)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE0EOuwSEnDJobFE1boMPRTZdtRyM_Gtz8ExDIhECk7GLsHd4VLjwetOBC0tcYUv7c7aESY6B1wOVDrGkf5rPD_VIbNMQXWGM_rHIqXTyhiJT5qx3jQhJZEDVunPojXbCBj50PDVDRMVNnSdh5-SMyT-OhU6WWdTg==)  
- [abbvie (4-23)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFkwwA0BjtpyBRDVTILEwWQHJE58o-wqCqSyWav2ut8428A7ig572dW1XODJXwWIo9CYSDHMxSYN3WOQeQRQIsUIWhcR0q5XAY_HHtpau4A-H1OvIytnFf82K2dH3gI)  
- [justia (4-24)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG2ndSUsYQjU7hwSm1OFspqlRncFPDhrhzLreAgLpmb58KR_39--uFiQGSGXv67ukSrO4u-Kmj5HOVCF4XnOlQFlKiDOt7F8zCWkxuKR5q9AVk2f82s98raLL6b-uIbgAiFfYFr8l1eNqYK9cpwsPoe)  
- [abbvie (5-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH8plBSOMe8DzPlnzS-77PRdWyIVUnqsh5kq9x_drLcp_GmyT5eWXoY9cKTzBEw5AoWMidDYEsFscfZY3RhlRAsQJS_6xmQe_juaDOqTByOvCXoDIS7MXZVhKbHc4BxkcLXvqZyrjTb3uR75DPcN3U8OI9yQ6QcC_VZ04voVGOxl4CM9D7YOCUcUuQ=)  
- [abbviecontractmfg (5-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFPkz1LLaz2KaNvbX0-8lsXvQRdoE32xDBSwugYbRgqNPpY4lpoX50Un4u36QvrlVaSc9n-uD4SiAOkC--47sfe9RrmfiUStWsbIV3G6DdIeeGUNZStEaNF4-OCvTIoY625jxip78SlfNXB9c7vLAEmG6ob_5UelTXJX6NxD8_NgjjzvJm_sXjpSl5wFEwqcNE=)  
- [abbvie (5-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGzNOjpXtqMLpKqn0w8juoyIRUazIsomnkc-z-Q1SrGZtnbQfKw_MhnysrlLy9mBKiP9BhQdQfxiPGl4P1Gz9tV1rxAUlFaoIU3CffaGoe5bUChPwO83J-i6GG9hGd88F49ewWaXZBiyDQO3SCgrQhUv5Qrlb7VgHWe3VoHX6lCiWQzzGLiC0bs8ec5Ow==)  
- [abbvie (5-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFDke4mVPTgkKa9C9uZEA5yIlWevuCD0G9H2jFYn3smqAdjsKuwW_1hjsLV2y1chqq3O9fZjaJByYQLAKAtVy9eM970qDiIAsmBlqeJwH_IBWn2TQTD-WiXzarIw_QichhLVjrwrJNYJOXLzImwZn9VsmVMT8Y-N_BDjwteLWFlmGM54kz58s4BUm1MuEbpkG6H5ZgJR4IUtaVvVEgEfvvSZeKEq9Q=)  
- [net0tracker (5-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGcreDqlR8peZ2MvcDVAV6GbCXvrko-9B792M9PU1Q9-qqV7vuoUA4enVldrWgn_AkW3trpJhdKVUtAVetw5r55UZRuCyopEg8BPONmB8Wyl9MPqgUWhVEJtbMe-wVmIl2NS1dpt9ok1boPrJPR1TYj)  
- [ditchcarbon (5-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGwfiXfn6fDcF3eUgHAfi-SJxLFMQNqSwNWEcMmSvlnQ9w2VSBmDlNQsDxyv7Szd6vlXilweM31QDgHPViODqosdyfXsIIfvTgFU1hQabJPyRnzQ9vQbwPE7qspd1VK03cZ5Sl5cIw=)  
- [mja (5-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEEwEz3jyvPH43feOvjN4BH5SikpTUaYOoNIpasx2TaA_FqQLDfNv5o1_z3WcuK4_1X5UH7NaKaQXlGIb0w4uNhSKfNvVPbl1onbBnpElDUtSqZABzHcc007KB-KUBDJvHeucLwdXaM43Hbm5sv6PsayQMiLNccqu8fhS07z-a3wuTkTLxs95TuGVdSySnOs1OP)  
- [abbvie (5-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFyBaAD3KDuE-zoNdmMqFhW_na4yarVx4tygCtL5GTOkfsEGwT01xY0w1vl7vZhhnBLUyHFpgGcpqsENfQ4TN7gKKBJ7yNAWmsz6QCgjiO9MKfS5RslUZo5-lBN50St2r-jQ_OIXZTm9ziHmoSD3UKfrZXgl1daGssF1KlGsrCbyNY9AV9fG5n5Fzs=)  
- [thesustainableinnovation (5-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE_p82OXskXwNdPIkeKfmk-bQgBc2S8usDElfsQb48od90vWsokHBRPpKFufcbM5pTg74PkxwiWrT0_th4NTJVdry_e_TuKfvV7hLUxTauhOSdew82MXbrZNQR2UKikfndryzJq1aQSgXSr5MXuufEKkB_aO6A=)  
- [abbvie (6-0)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG9WkQr4jLwTGVMs26iXPTBxjygQIGj7zFlxAKx7xRKVPa7AWmNbr9UbPwoi0zMuravNqY3snkb6NvuIAewVTVjOaiaVsSbES0xGlw9Umuhywmr0SVC0Qt1LqZW-uH4TnoJhmL9thu3NP1kyVogJ5XOUmSrbSC3yBUu4Qqta1hAbDUP85QiC4y9Iz8R)  
- [abbvie (6-1)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFnDPH0CEh9DgsI7UvK5yLUGBvkCzqGzm0tIHBrcPyVnotStO3ieDsDWjkTDnGBi393EgiCq0ORC2GJ0ECUpV1o8x_O8zUhEkC4dAF-lyYqH4rNJ_RyRiEhFhqWopnAha7mffJvtos8hZwlKx6n2kIe8elN-zYawgrRogiQbWDU3hdBtdfbUSPVjt8-188=)  
- [abbvie (6-2)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG1OfQVfJMLX3TudlWXcNorCfzSTtDAt33uI7UYrZvqeepk0UaWb685Wn3wAFObwYK7GgAFIe6vYqs-Rdao5aQA7QDwV1xK7OHvD4MipKQlm4aZGD4RneP_gR5JQtNNPkD1aw93jhy-i2XJOgOvJP2XiJjKTYJknH2EjDRrdL43EXgD924iQ7sLTjt_EvkFzw_8ztKofv2vqJZoJOWT52OJOOxJ0sWJ)  
- [net0tracker (6-3)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHosQ4addYSQ4MJU3ZPD5PwsPBeeHFQeQyPHP6gxepLjeq3AHatf7ho0gjykxb7cqMVjAmqAcPyvemqJqoYWkN7aMs5O-QlQq32bC98cz2HZFASLC2Z3CWnDO_9cNT0dQd6g4g28YuQ-_mlnIDjRwB-bw==)  
- [carboncredits (6-4)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE56NJORDZuUzloOtF_2ZM7SsAI-W16y5MsCf3S9u1SNXfuh-Uj__xisdbIwY0HwjezAMPcOptSn-Ipo1qAufWZSE3ma0N2x9zMJ-8LH-cV7E-uiRp8rETA0AqcdLFtsICpPUbHl8d3kpZD5QybEcufvF_jHr1WdkxycPJK)  
- [pfizer (6-5)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH8WHN-hAKJG-7OW5AzMfP7nlikcjCe8kUpxgyru1-N56ikEKiTqrLpLD862YKgGg-ZeU6ghNVzsMWEf2Scv4sGVjQ2aGAn-cIjQjv_EFN-SH98qNUyypi4--sL-_pDdQ1fcrdqcQ55nxebsSuKKZ2ENB7TeM-kvZwUY0wlgvSKH4GD3u625NcS5QlWiTPD)  
- [sustainabilitymag (6-6)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHmbQNiOjMlU4KIWLO9ryBjhhbfYKaP4vI9BcjPRQ15uMCuD9Sfzf4R5Go_SnMxCWInpm1F0_INUK8KAjNAKLS3efh43Div3gduq9ZVc31ZlYWzCBtLzGA0Sc0tIEBpW0sYq6y2UQWzfCAjpSuAI6MmfpbumKAWZ0dITD41LrJocGKgQVAlWtYsPc5Rki5u34acJM4=)  
- [jnj (6-7)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEnQZjHz8dYSjg6kGICvqO0MW_irkkUlzGBzpgawFUAaDpn8TADgdXiXI8dLegWEpDfE4PePGPjvm2GiWnvwhc2t_S-qm_e36couPzyeZrDsnDxfbsc4K87N_tGHXhf_CmYhVrLsz-BwNlcL5Qb-JzTHkVkWtGetMLE3Cmq_O-dBhuPRYPYFIIdiM-ZuXr25FKHtChEcLl1LEKJY5nm1QKUwW46RMo=)  
- [ophthalmologymanagement (6-8)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFRGEaAElK7SZh05ScZCW88gHhuyaSNaZBlQxCULEuVunZdVYE4GDESMuiBGZIdRxcc59WOSoU9mPKxMLhSX2RP6v54M1wqze5UUwjvmHIIoCGoGmebNh_Df_mChf49Psepz9nOhj3vvu_-5hGcd8xh3cOVhNn-HvH-q3G1DhQQFfbYs2OHGPEPVE46NbqiGMzzNvoYwyDFq1iUCX8gn8L1EBuNfqlZCPiFsT93eSiJjnVZ1ZWEsfrq9yXVYIFoZ6NtSScwEC-rVdHNkLBRTqi3vw==)  
- [esgtoday (6-9)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFh5uNtCwH1dKAEqb3ciWVJWA_dqErEx8MRXsHaay8_sVkvyBOfiASYgy3rYaOvnwT4oyro-JqyeJJpdrZir1PPOChEVZxQ1Ndf5PPV2tq0s3pwvaVKFYrNkqT6KwgChqBmk4Nod1oKoOtioYbD6wy6zpQS4cay7-GKMYhMmCfZ5M8Gbvts5EVZUx17tOmHPeEmiD8zX47uTELA4bBcpTkdx2LD)  
- [green-forum (6-10)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGb8pS5xyQAz2hOPqa9WnO4_iJ9k2H5XZgq7IHdGsFEII5aWYdmteYweFB9SRUGJ7Fo5f9ahUhG79OEqxtTl51QB15RR49j_b-oaKizmuo2ol0dV5i3YDFdYdGI8qVH-0ozy3Jr5-djHktivzJD_bBeEkS3kMCRuuReUHVi7zBvI2gzERjCdbTlK6tP_i6EKuiRKN4YlXsr0a7ZuxSsguK4D7q33g==)  
- [jnjmedtech (6-12)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGRG7F2CEKuJSjXUkp9nuYhMrUuxxLpvkXSYoGhyaW1Ll-dKO-ckvmYjScOSCBPb6MiW7BXrpc6SePUlsrWubYxXE3Ffbz-xvGnkQl2OHnS88_w80p4V8gcNvtN7gpEFAzWrzzyX3MJoou8u4mGgITgAbYNt-oULHJmyF17TQOkLW92eRK6ZYBeyeTwPc6amaBivTnsFwpFO7gDEZyoJLzRxpmk)  
- [netzeroportal (6-13)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGjYIssj-8tpz9rhw2lHZ7R4wVyO7RN1h1hhyiqw6tiqwOrss62BVhDwnXGxjdDj79OnYzoK1FTUM6BtgKjqzQFFXDnXuD8UlJSbYREpRlA8I4Xz7ya_KBkd7ogljKSIGisAqsAIeo=)  
- [novartis (6-14)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGPD_22s3vzVBvhvE2TyQzJRUlbE-zyuAgf_tJh1lAVtNGUs5rd82SXDCEEJV2oDw77AXi_61Asc6urWN7gzEv7n4MOBUAXKz-pNUQqXPsdY6iLeHHxvE9Xjs33jplY1F3TKkDUjOnJPw0TbaafuTHujzmFlnIG4cPjlBu3)  
- [fiercepharma (6-17)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEQQ8dFL1crDxlzVzpY8P5B5_8TLfGkRq_avpFsG4VgwcTRkvNcBIlv-ltToVZT8NZtxKvo-gry5m2CTMowhPGaCuMJkEzqzlJbjQB9rZpW6ByxXnCG0IrRok9UW8W7QwRVJOygvFphV_77wiCtrHzjHyg4jQNxFvZqodkIcgvsVKG9rvOTy2-b5GHrRxFfYix2nUalNClJIX1bpmFD)  
- [esgtoday (6-18)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF2kPz3ns1h7cfQbxIphDEtc8rJX29MoBDJvY6Jhe93JpeQ8-M09OSQgYEWbvh-XamSqDNl0Mr51ttjCepNo2XQPyIb5WhrLuqcWjvtnMpKDZ2c-mlQr_PNizthf56sjTa1mDJBHVbYxn_d5uDkAhfqbxXFzf7H0SZu2_g4VPg=)  
- [verdantix (6-19)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHgBphpTOh-UVvO6YrYAcgVxquh0-7RbP-y982-5Jgyy6avioYyfZ0ecf-7-j8ioLEK0ae5e-woMeAtYFP2KprdBTGVQGpDJVJEZj4DtrlvaLV-aSqKBlRLWfkLDzraeFeaX8i9RvBIzYrnxRY9-oHSYvogo54zCfrMFpGsZMCWrTwQujKa8ePnR_YeqnztOsbDyVXdjUUfLkeDjZhGM3SVREaOm-ZEL1ta10mTiA==)  
- [esgnews (6-20)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE4VZmPVJseRk5L01K2iFRCdOVv0vyvGvNdPnhvuXhgko7g5KEVxKQ6UsNT6NluU-49vSGh0MvvbkpLURRMLrPkpLPmS6E3L13q4jpCS9Ytm8YqX3-zj9AYBZn5WWeB2iINt97WIQennaazHWhAbokVZtXFlGtcbzBedhYsV8Qz7LP-SsLqHkHP-q7iiMgrVn-Z2pzQxnINj2TUXSMlreqktvy9MuUD8josyKN21VjLNg==)  
- [esgnews (6-21)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHPnE4TRCqFvj36sM2a9c0MouW1gWV1JoOyZ9GlXYxENA0BW_B0dy__K2lMn8HSQv5_GdSeOQWsMyH66EPSh0R77ZxtLXvl-OqPLd3PUg_zBb83a4RHwWh7_EUmBy3L21dja8eHrgj1nkXoeFAOMMlwUPbYEknd9ZbYmUp5LN9lnoC2iYbtQqkEuvPwYJFE7FzZwecuQrgxk42kee5FvTlAVWNnQozTaGVLDu0qaSIemBcCoaXu2ERV)  
- [abbviecontractmfg (6-22)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGtnKK5Ip19NNDg5XjkwouoO1E3UT1xdLLt890Z35DwWBLzdOzOQPyFurHwOSf7e7Yoju1mBc2b-2M_PkZzYAPlDIVsomdrZeVufjUmtmA_dx__XXsWegYbwFZrnCtKXbn0q3J4Hv-DxAZHIpNqDmHgvumSaGC5bWaUJLIATmY-CT2yl2lJHzA50u1rJyHCYVRW)  
- [smartenergydecisions (6-23)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHjCA_IqEkH5hB0CDaJ5vcxd_J7zMadis5J4k6Wjt4ts2dK5-CONPxgKxoPgKnx0dqAzZgNzxUiJ9vyciyTBGtrgkvOHy_qnfY7oeCNSkrmvfiqo7649tmFBXbXmNw-Fz1Xbw7DR70claDlqDB96V-wXrCypZzazN6ggCs=)  
- [net0tracker (6-25)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEgvqTNPGPBk0gldYzbuYLJaK1zGRX1a7KTALXcdYFn4Pqv4fFpY3CUeuJepQZEWcanHMVYI79EcPTogG9ZDjQ7y30kzCa7WLGklGxBKIPhcbNAr5i5tVSuK8q3PhB5vlkbu9sRykGQ5jmyjyhTqvII4g==)  
- [opensustainabilityindex (6-27)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGI-xvfLQlJ9aQyQtoYq_hz4_sfIWguf_guikbH_yBAYIywq-m9vvZrd4syPv4OP760nKZBEJJjJYoiy1FIxqBoMhuwQlTS-uLbddJJCTjLSsnKMgfGnRDzMGwZyN7C-RZYEN2ISZsA9Eq0f1nUkCPGsQ==)  
- [esgnews (6-29)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvdNxwobPQzGpVgBpoRIT4CLcUmLoNReLihcbRGLXEBGJXYxMMTOXTtyWGIIThERso3zNguO5p37AxrhVPajHQY8X8Qusa8N6gwaz77ZVx2oE_X363kY3w9f4Lv-5Z928DoVH2n0FoqMgVpV-EGu_itlAlqJFiVrItn_sQ31uv8e1ApW7tmMYllDDcpzq5byaKDMDeyNCidnGK-LIdvh1MCCWEvVjIQR8DmcUVM95pTRd6ekUwPUTaxYyR8vQNb9nEqvLDBSd3JrNWVIrQYJX4JeHGDMSj2ZLBMyvK)  
- [roche (6-30)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGrUGNnNE10I8HXGg9tIKqeAPIgVh7cQU1SaJI7IF4aw29-8WUE4breKjts9uXRWqNiCvAo_W5QQgUVhskvTqlSODAYT145K1PDBz-63_E6XGDgL7Cg2lApZrBh2-azzic6KaZfXHxxyHCrMtdfuF-J3jqfdF-Mu8g=)  
- [roche (6-31)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEbw7rUNaurNJcOd1LxKz-7e2nb6qm-1trLL8zvgsi6P3o_gSdG5vbHQsXgWEChXyXlyp4Js4IG5aHvur1g5Di9y8zqbBfl8vkf-Vosz4WWbM5R_ktVBuNCIe_zcbnyLqkWVXewVrYzco87pC04D9DNE15kIw-zJtj6OLwLzg==)  
- [roche (6-32)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF37241DFSw6Xzjddrkkwl6dErg3yh6JDc35E4SITZDrk2hF6tHaMuffnyjSh2tbOcDVMvR1hK6dZUKlgUSH4dv6d7ZNjMLyTflpVumGUW3GfzgTiVLJkbHonv9CAvm5FYIsDu_IyVZsInp9IVycLruHwjX3XaiJz4=)  
- [ditchcarbon (6-33)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFtwRSSmE5nM-fiHLXucROElEMVIha0PaZt3X8xp3Fda3Bp4P4XYQXPCXc5LnvN2Gtr8KbOEm4y_1i59L-n9kA0aKNTtj1ba5o6dpPcI4_bvn3yvI_Bd49tCQ8hwMCAG1MgYtgTq9dk)  
- [europeanpharmaceuticalreview (6-34)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHDXXK0dFOLI6I9wDSV4jP34EB9fSSoiP4zWoBiJ1N0c43Gr1I4HABFYcGOOCDAEQnfeRDuXFFezJXz4wCcWj7vgOpC0MyroYayNOkTFSe15tlDC91aUbYlvP35AnfBKt8WF7NzRs-WUtTYhprgCI1Vr4GYiZpMYuuYYuI6r46YxBsJBW6vtX9abk1Nq9eZcDhicmvjeXXAuUOJzOQ=)  
- [pharmaceutical-technology (6-17)](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEQQ8dFL1crDxlzVzpY8P5B5_8TLfGkRq_avpFsG4VgwcTRkvNcBIlv-ltToVZT8NZtxKvo-gry5m2CTMowhPGaCuMJkEzqzlJbjQB9rZpW6ByxXnCG0IrRok9UW8W7QwRVJOygvFphV_77wiCtrHzjHyg4jQNxFvZqodkIcgvsVKG9rvOTy2-b5GHrRxFfYix2nUalNClJIX1bpmFD)

If you want, I can:
- produce a peer‑comparison table quantifying renewable electricity %, Scope 1+2 reductions, net‑zero year, and notable tech pilots for AbbVie vs Pfizer, J&J, Novartis and Roche (2022–2025), with source links; or
- dig deeper into AbbVie’s site‑level deployments (e.g., on‑site MW capacity, PPA details) to refine the Technology Adoption score.